Pfizer Inc
(MIL:1PFE)
€
24.62
-0.33 (-1.32%)
Market Cap: 140.00 Bil
Enterprise Value: 193.63 Bil
PE Ratio: 34.77
PB Ratio: 1.58
GF Score: 59/100 Pfizer Inc at JPMorgan Healthcare Conference Transcript
Jan 08, 2024 / 11:00PM GMT
Release Date Price:
€26.85
(+0.19%)
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be hosting a fireside chat today with Albert Bourla, Chairman and CEO of Pfizer. So Albert, Happy New Year. Thanks for joining us.
Albert Bourla
Pfizer Inc. - Chairman of the Board & CEO
Happy New Year.
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
I know you want to make some quick opening remarks, and then we'll jump right into the conversation from there.
Albert Bourla
Pfizer Inc. - Chairman of the Board & CEO
That will be fantastic. First of all, I was instructed that you should all read very carefully this statement here, Legal insist on that. But I wanted to make a few comments before we go into the questions.
So clearly, 2023 was not a good year for us. We missed our internal projections and also, we missed the expectations of The Street.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot